Actively Recruiting
Atomized Inhalation ICG for Treatment of Congenital Lung Malformations
Led by Jiexiong Feng · Updated on 2024-10-16
50
Participants Needed
1
Research Sites
1400 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To investigate the safety and effectiveness of preoperative aerosol inhalation ICG solution for thoracoscopic accurate resection of congenital lung malformations in children.
CONDITIONS
Official Title
Atomized Inhalation ICG for Treatment of Congenital Lung Malformations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children with congenital lung malformations diagnosed by CT or MRI scan
You will not qualify if you...
- Age less than 3 months or over 14 years
- Complicated with other life-threatening diseases
- Severe pulmonary infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tongji Hospital
Wuhan, Hubei, China, 430030
Actively Recruiting
Research Team
T
Tianqi Zhu, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here